A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Women's Cancers Bookmark and Share

Women's Cancers

The power of collaboration and a dedication to compassion
 
The Women’s Cancers Program at City of Hope brings together medical doctors and laboratory researchers from across City of Hope who are committed to increasing our understanding of the risks for developing breast and gynecologic (uterus, ovary, and cervix) cancers, developing novel strategies for treatment and prevention, and improving the lives of patients. These unique collaborations result in the rapid translation of scientific discoveries into more effective treatments for breast and gynecologic cancers.
 
 
Changing our patients' lives today

Our research serves as the foundation for developing new treatments for women diagnosed with cancer. Educating women about risk reduction, disease management, and post-treatment care is a major element of the program. We offer a wide range of clinical services, including screening/imaging/diagnostic approaches; genetic counseling and risk assessment; multidisciplinary therapeutic interventions including surgery, medical oncology, radiation oncology and reconstructive surgery procedures; rehabilitation and supportive care; long-term follow-up care; and prevention strategies.
 
We are the only women’s cancers program in the country to offer a biopsychosocial approach to care. We focus not just on the disease but on the biological, psychological and social factors that play a significant role in the lives of women battling cancer.
 
The Women's Cancers Program at City of Hope is among only a few in the nation to offer minimally invasive robotic surgery using the da Vinci S HD Surgical System. This robotic surgical approach offers greater accuracy, smaller incisions, less postoperative pain and faster healing.
 
We are among a few women’s cancers programs in the country to routinely use intraperitoneal (IP) chemotherapy to treat certain types of gynecologic cancer, which can greatly improve the outcomes for women with advanced disease.

Our patients are given the opportunity to participate in clinical trials. We are constantly evaluating new drugs and developing better treatments for breast and gynecologic cancers, designed to improve the likelihood of a cure. Many of these new treatment approaches are available only at City of Hope.

The Women’s Cancers Program at City of Hope, one of the largest in Southern California, continues to grow to meet the need for highly specialized and leading cancer care. We are at the forefront of breast and gynecologic cancer treatment and research, and we take a comprehensive and aggressive approach to provide the most advanced treatments available.

Care continues after treatment

Our doctors and researchers are working to develop resources to help improve the lives of women after treatment, and all patients are able to participate in ongoing long-term research that focuses on life after cancer.
 

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Development Officer
Phone: 626-218-6250
Email: jmorgan@coh.org

 
 

Women's Cancers

Women's Cancers

The power of collaboration and a dedication to compassion
 
The Women’s Cancers Program at City of Hope brings together medical doctors and laboratory researchers from across City of Hope who are committed to increasing our understanding of the risks for developing breast and gynecologic (uterus, ovary, and cervix) cancers, developing novel strategies for treatment and prevention, and improving the lives of patients. These unique collaborations result in the rapid translation of scientific discoveries into more effective treatments for breast and gynecologic cancers.
 
 
Changing our patients' lives today

Our research serves as the foundation for developing new treatments for women diagnosed with cancer. Educating women about risk reduction, disease management, and post-treatment care is a major element of the program. We offer a wide range of clinical services, including screening/imaging/diagnostic approaches; genetic counseling and risk assessment; multidisciplinary therapeutic interventions including surgery, medical oncology, radiation oncology and reconstructive surgery procedures; rehabilitation and supportive care; long-term follow-up care; and prevention strategies.
 
We are the only women’s cancers program in the country to offer a biopsychosocial approach to care. We focus not just on the disease but on the biological, psychological and social factors that play a significant role in the lives of women battling cancer.
 
The Women's Cancers Program at City of Hope is among only a few in the nation to offer minimally invasive robotic surgery using the da Vinci S HD Surgical System. This robotic surgical approach offers greater accuracy, smaller incisions, less postoperative pain and faster healing.
 
We are among a few women’s cancers programs in the country to routinely use intraperitoneal (IP) chemotherapy to treat certain types of gynecologic cancer, which can greatly improve the outcomes for women with advanced disease.

Our patients are given the opportunity to participate in clinical trials. We are constantly evaluating new drugs and developing better treatments for breast and gynecologic cancers, designed to improve the likelihood of a cure. Many of these new treatment approaches are available only at City of Hope.

The Women’s Cancers Program at City of Hope, one of the largest in Southern California, continues to grow to meet the need for highly specialized and leading cancer care. We are at the forefront of breast and gynecologic cancer treatment and research, and we take a comprehensive and aggressive approach to provide the most advanced treatments available.

Care continues after treatment

Our doctors and researchers are working to develop resources to help improve the lives of women after treatment, and all patients are able to participate in ongoing long-term research that focuses on life after cancer.
 

Support This Program

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Development Officer
Phone: 626-218-6250
Email: jmorgan@coh.org

 
 
Quick Links
The Positive Image Center is where licensed cosmetologists support and assist patients with building and maintaining self-confidence in their appearance. Patients can access wig fittings and stylings and discuss cosmetic techniques.
 
Cooper Finkel Women’s Health Center
Many gynecological cancer and breast cancer  services at City of Hope are provided at the Rita Cooper Finkel and J. William Finkel Women's Health Center. Here, women receive the highest quality care, whether seeking prevention and screening services or coping with a cancer diagnosis.
Physicians in the United States and throughout the world are welcome to refer patients to City of Hope.

There are a number of options you can choose from to refer a patient:

 
Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 


NEWS & UPDATES
  • We’ve all heard the mantra: Cancer screening saves lives. And it does, especially with colorectal cancer. Regular colonoscopies have been proven to reduce the risk of colorectal cancer death by up to 70 percent. Screening for colorectal cancer using the even simpler fecal occult blood tests has been found to re...
  • Pick up any biotech industry report and you’re guaranteed to come across one term repeatedly – CAR-T therapy. A fierce competition is now underway to bring CAR-T treatments to market – several companies (Juno, Novartis, Kite and Cellectis, to name a few) have major stakes in the race. I’ve found the CAR-T buzz ...
  • Patients undergoing treatment at City of Hope know they will be receiving the best medical care available, that their treatment will be delivered with compassion and that their care will extend to their families. “When we treat a patient here, we treat a family,” says Jo Ann S. Namm, child life manager and spec...
  • Did you know that colorectal cancer equally affects men and women? Or that it’s the third-leading cause of cancer death in the U.S.? Most important, did you know that colorectal cancer is very treatable and highly curable if detected early? If you didn’t know these facts, it’s time to learn. M...
  • To celebrate the beginning of Lunar New  Year 2015, City of Hope honored not just a new lunar calendar, but also the diversity of the community it serves. On Jan. 21, as tens of thousands of people celebrated Lunar New Year (and the arrival of the Year of the Ram) in the streets of L.A.’s Chinatown, City of [&#...
  • The breakthroughs that have revolutionized cancer treatment, transforming cancer in many cases to a very manageable and even curable disease, started out as just ideas. “I will often tell patients there’s no therapy we’re using to help them that wasn’t derived from somebody’s idea in some laboratory, working la...
  • The prostate cancer screening debate, at least as it relates to regular assessment of prostate specific antigen levels, is far from over. The U.S. Preventive Services Task Force recommended against routine PSA screening for prostate cancer in 2012, maintaining that the routine use of the PSA blood test does mor...
  • Cancer patients should get more than medical treatment. They should get comprehensive, evidence-based care that addresses their full range of needs. That kind of patient-focused care is City of Hope’s specialty. Under the guidance of Dawn Gross, M.D., Ph.D., the new Arthur M. Coppola Family Chair in Suppo...
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...